AC
PFE icon

AFAM Capital’s Pfizer PFE Stock Holding History

AFAM Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$4.03M Sell
96,338
-376
-0.4% -$14.5K 0.56% 80
2018
Q2 		$3.33M Buy
96,714
+763
+0.8% +$26.1K 0.48% 81
2018
Q1 		$3.23M Buy
95,951
+3,665
+4% +$126K 0.36% 114
2017
Q4 		$3.17M Buy
92,286
+3,086
+3% +$105K 0.35% 118
2017
Q3 		$3.02M Buy
89,200
+2,096
+2% +$67.4K 0.36% 115
2017
Q2 		$2.78M Buy
87,104
+8,491
+11% +$268K 0.36% 111
2017
Q1 		$2.55M Buy
78,613
+468
+0.6% +$14.8K 0.35% 110
2016
Q4 		$2.41M Buy
78,145
+1,453
+2% +$44.4K 0.36% 104
2016
Q3 		$2.46M Sell
76,692
-3,049
-4% -$102K 0.39% 101
2016
Q2 		$2.66M Sell
79,741
-2,980
-4% -$95.1K 0.44% 98
2016
Q1 		$2.33M Buy
82,721
+1,685
+2% +$48.1K 0.38% 104
2015
Q4 		$2.48M Buy
81,036
+4,527
+6% +$142K 0.38% 100
2015
Q3 		$2.28M Sell
76,509
-508
-0.7% -$16.3K 0.35% 102
2015
Q2 		$2.45M Buy
77,017
+1,923
+3% +$62.7K 0.33% 108
2015
Q1 		$2.48M Buy
75,094
+3,777
+5% +$120K 0.32% 105
2014
Q4 		$2.11M Sell
71,317
-64
-0.1% -$1.83K 0.27% 101
2014
Q3 		$2M Buy
71,381
+1,184
+2% +$33.2K 0.25% 103
2014
Q2 		$1.98M Buy
70,197
+664
+1% +$18.9K 0.25% 110
2014
Q1 		$2.12M Buy
69,533
+3,095
+5% +$92.3K 0.28% 108
2013
Q4 		$1.93M Buy
66,438
+3,001
+5% +$87.3K 0.26% 106
2013
Q3 		$1.73M Buy
63,437
+26,965
+74% +$734K 0.24% 106
2013
Q2 		$969K Buy
+36,472
New +$1.01M 0.13% 123

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AFAM Capital's PFE Position: Q3 2018 in Review

AFAM Capital reduced its Pfizer (PFE) stake by 0.39% in Q3 2018, selling an estimated $14.5K and leaving 96,338 shares worth $4.03M. The position accounts for 0.56% of the portfolio, ranked #80.

AFAM Capital first reported a position in PFE in Q2 2013 and has held it in 22 quarters since. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

  • AFAM Capital held 96,338 shares of Pfizer worth $4.03M as of Q3 2018.
  • AFAM Capital sold 376 Pfizer shares in Q3 2018, an estimated $14.5K.
  • Pfizer made up 0.56% of AFAM Capital's portfolio in Q3 2018, its #80 holding.
  • AFAM Capital first reported a position in Pfizer in Q2 2013 and has held it in 22 quarters since.
  • 2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.